In this educational activity, experts will present real-world cases that review best practices in the early diagnosis of meibomian gland dysfunction, review current treatment strategies, and discuss emerging treatments for meibomian gland dysfunction.

This educational activity is intended to help clinicians identify patients with thyroid eye disease who require intervention for elevated blood glucose levels prior to treatment for thyroid eye disease with the insulin-like growth factor 1 receptor antagonist teprotumumab.

Following this educational activity, clinicians will be able to identify opportunities for early referral of patients with diabetic retinopathy/diabetic macular edema and choose appropriate strategies for comanagement of patients with retinal disease.

This is Part 2 of a 2-part educational activity series designed to enable optometrists to successfully implement pharmacologic treatments for presbyopia for appropriately selected patients.